Skip to main content
. Author manuscript; available in PMC: 2023 Oct 20.
Published in final edited form as: Ann Thorac Surg. 2023 Mar 31;116(1):156–162. doi: 10.1016/j.athoracsur.2023.02.062

TABLE 2.

Univariable Comparison of Patient Characteristics Between High- and Lower-Volume Centers

Variable n Overall
(N = 593)
High-Volume
(n = 412)
Lower-Volume
(n = 181)
P Valuea
Age at listing, y 593 49 (37-57) 49 (37-57) 51 (37-57) .39
Diagnosis group 593 .54
 Obstructive 12 (2.0) 10 (2.4) 2 (1.1)
 Pulmonary hypertension 43 (7.3) 27 (6.6) 16 (8.8)
 Restrictive 488 (82) 339 (82) 149 (82)
 Suppurative 50 (8.4) 36 (8.7) 14 (7.7)
Sex 593 .57
 Female 223 (38) 158 (38) 65 (36)
 Male 370 (62) 254 (62) 116 (64)
Blood type 593 .54
 A 192 (32) 138 (33) 54 (30)
 AB 29 (4.9) 17 (4.1) 12 (6.6)
 B 74 (12) 51 (12) 23 (13)
 O 298 (50) 206 (50) 92 (51)
Prostaglandin infusions at listing 593 14 (2.4) 10 (2.4) 4 (2.2) >.99
Resistant infection 569 29 (5.1) 21 (5.2) 8 (4.9) .88
Diabetes 591 165 (28) 120 (29) 45 (25) .27
Ventilator at listing 593 322 (54) 248 (60) 74 (41) <.001
Body mass index, kg/m2 592 26.5 (22.9-29.8) 26.4 (22.9-29.6) 26.6 (23.0-29.9) .52
Pulmonary arterial mean pressure, mmHg 391 29 (23-40) 30 (23-40) 29 (22-41) .75
Cardiac output, L/min 353 5.4 (4.3-6.9) 5.5 (4.4-7.1) 5.2 (4.1-6.6) .14
Creatinine, mg/dL 593 0.60 (0.47-0.81) 0.60 (0.46-0.81) 0.61 (0.50-0.80) .48
Days on waitlist 593 9 (5-21) 9 (5-21) 11 (5-22) .22
LAS at listing 593 88 (85-90) 88 (86-90) 88 (84-90) .053
Center volume, annual 593 54 (29-78) 71 (54-95) 23 (18-27) <.001
Waitlist outcome 593 < .001
 Died on waitlist 148 (25) 86 (21) 62 (34)
 Transplanted 445 (75) 326 (79) 119 (66)
a

Wilcoxon rank sum test; Pearson’s χ2 test; Fisher’s exact test. Values are presented as median (interquartile range) or n (%). LAS, lung allocation score.